霉酚酸酯治疗肝移植后丙型肝炎病毒再感染患者的意义：对临床病程和组织学损伤的影响。 - Suppr

Suppr

超能文献

Significance of mycophenolate mofetil treatment in patients with HCV reinfection after liver transplantation: impact on clinical course and histologic damage.

作者信息

Bahra M, Neumann U P, Harren M, Jacob D, Langrehr J M, Berg T, Neuhaus R, Neuhaus P

机构信息

Department of Surgery, Charité Campus Virchow-Klinikum, Humboldt-University, Berlin, Germany.

出版信息

Transplant Proc. 2002 Nov;34(7):2934-5. doi: 10.1016/s0041-1345(02)03494-2.

DOI:10.1016/s0041-1345(02)03494-2

PMID:12431663

Abstract

摘要

相似文献

Significance of mycophenolate mofetil treatment in patients with HCV reinfection after liver transplantation: impact on clinical course and histologic damage.

Transplant Proc. 2002 Nov;34(7):2934-5. doi: 10.1016/s0041-1345(02)03494-2.

Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation.

Transplant Proc. 1998 Jun;30(4):1468-9. doi: 10.1016/s0041-1345(98)00319-4.

Indication for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantation.

Transplant Proc. 1998 Aug;30(5):2232-3. doi: 10.1016/s0041-1345(98)00602-2.

Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil.

Transplant Proc. 2002 Aug;34(5):1563-4. doi: 10.1016/s0041-1345(02)03023-3.

Trough level-guided mycophenolate mofetil rejection prophylaxis in liver transplantation.

Transplant Proc. 2001 May;33(3):2154-6. doi: 10.1016/s0041-1345(01)01925-x.

Mycophenolate mofetil rescue therapy in liver transplant recipients.

Transplant Proc. 1997 Feb-Mar;29(1-2):549-52. doi: 10.1016/s0041-1345(96)00262-x.

Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation.

Liver Transpl. 2001 Dec;7(12):1064-70. doi: 10.1053/jlts.2001.29414.

Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus.

Transplant Proc. 2002 Aug;34(5):1503. doi: 10.1016/s0041-1345(02)02948-2.

A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.

Liver Transpl. 2002 Jan;8(1):40-6. doi: 10.1053/jlts.2002.29763.

Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus.

Transplant Proc. 2003 Aug;35(5):1877-9. doi: 10.1016/s0041-1345(03)00644-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Significance of mycophenolate mofetil treatment in patients with HCV reinfection after liver transplantation: impact on clinical course and histologic damage.

Transplant Proc. 2002 Nov;34(7):2934-5. doi: 10.1016/s0041-1345(02)03494-2.

Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation.

Transplant Proc. 1998 Jun;30(4):1468-9. doi: 10.1016/s0041-1345(98)00319-4.

Indication for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantation.

Transplant Proc. 1998 Aug;30(5):2232-3. doi: 10.1016/s0041-1345(98)00602-2.

Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil.

Transplant Proc. 2002 Aug;34(5):1563-4. doi: 10.1016/s0041-1345(02)03023-3.

Trough level-guided mycophenolate mofetil rejection prophylaxis in liver transplantation.

Transplant Proc. 2001 May;33(3):2154-6. doi: 10.1016/s0041-1345(01)01925-x.

Mycophenolate mofetil rescue therapy in liver transplant recipients.

Transplant Proc. 1997 Feb-Mar;29(1-2):549-52. doi: 10.1016/s0041-1345(96)00262-x.

Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation.

Liver Transpl. 2001 Dec;7(12):1064-70. doi: 10.1053/jlts.2001.29414.

Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus.

Transplant Proc. 2002 Aug;34(5):1503. doi: 10.1016/s0041-1345(02)02948-2.

A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.

Liver Transpl. 2002 Jan;8(1):40-6. doi: 10.1053/jlts.2002.29763.

Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus.

Transplant Proc. 2003 Aug;35(5):1877-9. doi: 10.1016/s0041-1345(03)00644-4.

Significance of mycophenolate mofetil treatment in patients with HCV reinfection after liver transplantation: impact on clinical course and histologic damage.

作者信息

Bahra M, Neumann U P, Harren M, Jacob D, Langrehr J M, Berg T, Neuhaus R, Neuhaus P

机构信息

Department of Surgery, Charité Campus Virchow-Klinikum, Humboldt-University, Berlin, Germany.

出版信息

Transplant Proc. 2002 Nov;34(7):2934-5. doi: 10.1016/s0041-1345(02)03494-2.

DOI:10.1016/s0041-1345(02)03494-2

PMID:12431663

Abstract

摘要